Rajendra Ketkar | President and Chief Executive Officer |
Matthew Plavan | CFO of Arcadia and President of Arcadia Specialty Genomics |
Sarah Reiter | Chief Commercial Officer |
Raghuram Selvaraju | H.C. Wainwright |
Ben Klieve | National Securities |
Robert Smith | Center for Performance Investing |
Good afternoon, and welcome to Arcadia Biosciences’ Second Quarter 2019 Earnings Conference Call. Today's presenters will be Raj Ketkar, President and CEO; Matt Plavan, CFO of Arcadia and President of Arcadia Specialty Genomics and Sarah Reiter, Chief Commercial Officer. This call is being webcast, and you can refer to the Company's press release and slides at arcadiabio.com.
Before we start, if you refer to Slide 2, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information.
However, since these statements are based on factors that involve risk and uncertainties, the Company's actual performance and results may differ materially from those described or implied today.